On July 6, the U.S. Food and Drug Administration’s (FDA’s) Center for Food Safety and Applied Nutrition (CFSAN) and Office of Food Policy and Response (OFPR) released an updated list of draft and final guidance topics that will be a priority for the …
The Food and Drug Administration (FDA) came under harsh criticism this past year after a commercial infant shortage formula in the U.S. For months, Congress and parent advocacy groups have been pressuring the agency to investigate why this crisis eru…
The Financial Services Committee (FSC) of the House of Representatives recently held a hearing on the reauthorization of the Terrorism Risk Insurance Act, also known as TRIA, which expires on December 31, 2020. This risk-financing mechanism has prove…
One of the biggest challenges in risk management is the concept of things “probable” versus things “possible.” Traditional risk management has focused more on the probable, using historical losses and other data to actuarially forecast future losses …
In our Insights for 2017 forecast released earlier this year, one area in which we anticipated significant changes affecting employers was the regulatory arena. That prediction came true this week with the approval of a congressional resolution lim…
It’s a topic that gets much buzz – how will the cloud of legislation surrounding recreational and medical marijuana use impact businesses, specifically when it comes to compensability for workers’ compensation? I am sure you have all caught up on n…
It has been stated repeatedly that the Affordable Care Act (ACA) with its 900+ pages is the single most controversial law passed by Congress in the last 10 years. Since the ACA was signed into law in March 2010, the industry has been buzzing about th…